This inventor holds 2 USPTO granted patents. Top assignees: Dyne Therapeutics, Inc., Hercules Capital, Inc., as Agent. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Timothy Weeden
Introduction
Timothy Weeden is an accomplished inventor known for his significant contributions to the field of biotechnology. He has developed innovative solutions aimed at addressing critical health issues, particularly in the realm of muscular dystrophy.
Latest Patents
Timothy Weeden holds a patent titled "Muscle Targeting Complexes Comprising an Anti-Transferrin Receptor Antibody Linked to an Oligonucleotide and Method of Use Thereof to Treat Duchenne Muscular Dystrophy." This patent represents a breakthrough in the treatment of Duchenne muscular dystrophy, showcasing his commitment to advancing medical science.
Career Highlights
Weeden is currently employed at Hercules Capital, Inc., where he serves as an Agent. His role at the company allows him to leverage his expertise in innovation and patent development, contributing to the growth of the biotechnology sector.
Collaborations
Throughout his career, Timothy has collaborated with notable professionals in the field, including Romesh R Subramanian and Mohammed T Qatanani. These partnerships have enhanced his research and development efforts, leading to impactful advancements in medical treatments.
Conclusion
Timothy Weeden's work exemplifies the spirit of innovation in biotechnology. His patent and career achievements reflect his dedication to improving health outcomes for individuals affected by muscular dystrophy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile